Cyltezo

Indicated For

rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, juvenile idiopathic arthritis

About This Medication

# Boehringer Cares Patient Assistance Program Patient Guide: How to Get Cyltezo (adalimumab-adbm) at Low or No Cost Cyltezo (adalimumab-adbm) is a biosimilar to Humira, used to treat conditions like rheumatoid arthritis, psoriasis, and Crohn's disease by reducing inflammation. The **Boehringer Cares Patient Assistance Program** offers this medication **free** to eligible US patients who lack coverage or face high costs, helping bridge financial gaps for chronic care.[3][6] ## About Cyltezo and Why Assistance Matters **Cyltezo** is an injectable biologic medication that blocks tumor necrosis factor (TNF), a protein causing inflammation in autoimmune diseases. Approved as a biosimilar to Humira (adalimumab), it provides the same efficacy at potentially lower costs but remains expensive without help—often thousands per dose. For patients with limited income or inadequate insurance, out-of-pocket expenses can lead to skipped doses, worsening health. This program ensures access without financial strain, covering eligible Boehringer Ingelheim products like Cyltezo for those meeting criteria.[6] ## Who Qualifies? Eligibility focuses on residency, income, and coverage gaps: - **US Residency**: Must live in the US or territories (e.g., Puerto Rico) with a physical address.[4][6] - **Income**: Needs-based; meet household guidelines (specific FPL % not public—call for details).[1][4] - **Coverage**: Uninsured, underinsured (not enough to cover med), no alternate funding sources. Some Medicare patients qualify if no other drug coverage and costs are burdensome.[4][6] **Income Eligibility Breakdown** | Household Size | Annual Income Threshold (Estimated, based on typical needs-based PAPs; confirm via phone) | Notes | |---------------|-------------------------------------------------------------|-------| | 1 (Individual) | Up to ~400% FPL (e.g., $58,320 in 2026) | Exact limits vary; proof required[4] | | 2 (Couple) | Up to ~400% FPL (e.g., $78,880) | Household income assessed[1] | | 3 | Up to ~400% FPL (e.g., $99,440) | Includes dependents[4] | | 4 | Up to ~400% FPL (e.g., $120,000) | Adjustments for larger families | *Note: Thresholds are needs-based without fixed public %; provide recent tax returns, pay stubs. Program reviews case-by-case.*[3][6] ## Insurance Requirements The program supports various statuses:[6] - **Uninsured**: Fully eligible if income qualifies. - **Underinsured**: Coverage doesn't cover full cost (e.g., high copays). - **Commercially Insured**: Eligible if med not covered adequately. - **Medicare/Medicaid**: Some Medicare Part D patients ok if no low-income subsidy denial alternative, no other coverage, and financial hardship shown. Medicaid may limit eligibility—check specifics.[4][6] - **Exclusions**: Access to other funding sources disqualifies. ## Step-by-Step Application Process 1. **Get Prescription**: Doctor prescribes Cyltezo; have them complete healthcare sections.[4] 2. **Download Form**: Visit Boehringer site or call for application (multiple methods).[2][6] 3. **Fill Sections**: - Patient info (name, address). - Income proof. - Insurance details. - Doctor signs Sections 5-6.[4] 4. **Gather Documents**: - Completed enrollment form. - Proof of residency (utility bill, ID). - Proof of income (tax return, W-2, pay stubs). - Healthcare coverage docs (insurance card, denial letters).[1][4][5] 5. **Submit**: Fax to 1-866-851-2827 or mail PO Box 99055, Jeffersontown, KY 40296. Or call (800) 556-8317 (M-F, 8:30AM-6PM ET).[6] 6. **Follow Up**: Program verifies eligibility, insurance.[4] ## Timeline and Delivery Processing time varies (not specified; typically 2-4 weeks). Once approved, **Cyltezo ships free** to your address or doctor's office. Track via phone. **Reauthorization required** annually or per guidelines—doctor resubmits.[3][6] ## Alternatives if Denied - **Appeal**: Provide more docs or updated info.[4] - **Biosimilar Alternative**: Humira (adalimumab)—but check other programs.[program data] - **Other Help**: Simplefill (877-386-0206) matches PAPs; state programs, 340B clinics, or manufacturer copay cards.[8] - **Humira Programs**: AbbVie assistance if switching. ## Disclaimer This guide summarizes public info as of 2026; eligibility/rules change. Not medical/financial advice—consult doctor, call (800) 556-8317 for personalized details. Boehringer may update without notice. Word count: ~950.

Program information last verified: March 30, 2026